Latvian pharmaceutical company Ltd. 'Silvanols' in collaboration with the Pharmaceutical and Health Promotion Society 'Innovative Technology and Health Promotion Institute' (ITVVI) started to implement a project for a use of pine oil fractions for the cancer treatment. Silvanols Ltd., Pharmaceutical and Health Promotion Society 'Innovative Technology and Health Promotion Institute' (ITVVI) and the National Education and Development Agency in the 29th of November 29, 2010 signed a contract Nr.2010/0263/2DP/2.1.1.1.0/10/APIA / VIAA/172 for the project "Pine strain of heavy oil fractions, anticancer and antioxidative activities research" implementation. Aim of the Project is related to the biomedical and pharmaceutical industry and includes industrial strains of pine oil tailings use in treating cancer. The project is being implemented by the State Education Development Agency, and is funded by the European Regional Development Fund (ERDF) funds. Planned implementation period - 2 years and attributable project funding comprises 148 899 LVL.